These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7573434)

  • 41. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
    Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
    Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
    Basu R; Schwenk WF; Rizza RA
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E55-62. PubMed ID: 14982753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
    Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
    Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes.
    Tessari P; Biolo G; Bruttomesso D; Inchiostro S; Panebianco G; Vedovato M; Fongher C; Tiengo A
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1553-60. PubMed ID: 7989455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.
    Nurjhan N; Consoli A; Gerich J
    J Clin Invest; 1992 Jan; 89(1):169-75. PubMed ID: 1729269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental validation of a glucose-insulin control model to stimulate patterns in glucose turnover.
    Fischer U; Salzsieder E; Freyse EJ; Albrecht G
    Comput Methods Programs Biomed; 1990; 32(3-4):249-58. PubMed ID: 2249424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theory of production rate calculations in steady and non-steady states and its application to glucose metabolism.
    Jacquez JA
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E779-90. PubMed ID: 1616015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Errors in estimating neonatal production of glucose with stable isotopes during "approximate steady state".
    Groth T; Ewald U; Gustafsson J
    Scand J Clin Lab Invest; 2001; 61(8):663-79. PubMed ID: 11768326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of hepatic glucose output in non-steady state. The simultaneous use of 2-3H-glucose and 14C-glucose in the dog.
    Issekutz TB; Issekutz B; Elahi D
    Can J Physiol Pharmacol; 1974 Apr; 52(2):215-24. PubMed ID: 4838182
    [No Abstract]   [Full Text] [Related]  

  • 51. Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods.
    Mari A; Wahren J; DeFronzo RA; Ferrannini E
    Metabolism; 1994 Nov; 43(11):1419-25. PubMed ID: 7968597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental validation of measurements of glucose turnover in nonsteady state.
    Radziuk J; Norwich KH; Vranic M
    Am J Physiol; 1978 Jan; 234(1):E84-93. PubMed ID: 623255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of glucose turnover, body mass and recycling with reversible and irreversible tracers.
    Katz J; Rostami H; Dunn A
    Biochem J; 1974 Jul; 142(1):161-70. PubMed ID: 4441369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of the rate of appearance in the non-steady state with a two-compartment model.
    Mari A
    Am J Physiol; 1992 Aug; 263(2 Pt 1):E400-15. PubMed ID: 1514623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans.
    Butler PC; Caumo A; Zerman A; O'Brien PC; Cobelli C; Rizza RA
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E548-60. PubMed ID: 8476033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error.
    Katz H; Butler P; Homan M; Zerman A; Caumo A; Cobelli C; Rizza R
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E561-6. PubMed ID: 8476034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants.
    Butler PC; Kryshak EJ; Schwenk WF; Haymond MW; Rizza RA
    Diabetes; 1990 Feb; 39(2):217-25. PubMed ID: 2227130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucose effectiveness: measurement in diabetic and nondiabetic humans.
    Basu A; Rizza RA
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S157-65. PubMed ID: 11460567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose turnover in presence of changing glucose concentrations: error analysis for glucose disappearance.
    Caumo A; Homan M; Katz H; Cobelli C; Rizza R
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E557-67. PubMed ID: 7573434
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.